Emerging Risks Due to New Injecting Patterns in Hungary During Austerity Times

Authors:
  • MDMária Dudás
    Mária Dudás
  • ERErzsébet Rusvai
    Erzsébet Rusvai
  • BTBálint Tresó
    Bálint Tresó
  • ÁCÁgnes Csohán
    Ágnes Csohán

Abstract
As a consequence of the massive restructuring of drug availability, heroin injection in Hungary was largely replaced by the injecting of new psychoactive substances (NPS) starting in 2010. In the following years in our sero-prevalence studies we documented higher levels of injecting paraphernalia sharing, daily injection-times, syringe reuse, and HCV prevalence among stimulant injectors, especially among NPS injectors. Despite the increasing demand, in 2012 the number of syringes distributed dropped by 35% due to austerity measures. Effects of drug market changes and the economic recession may have future epidemiological consequences. Study limitations are noted and future needed research is suggested.

This publication has 27 references indexed in Scilit: